论文信息 - 525O A phase I dose escalation study of PRS-343, a HER2/4-1BB bispecific molecule, in patients with HER2-positive malignancies - 字舞流文

525O A phase I dose escalation study of PRS-343, a HER2/4-1BB bispecific molecule, in patients with HER2-positive malignancies

A. Tolcher | G. Ku | A. El-Khoueiry | I. Bruns | A. Patnaik | J. Bendell | S. Piha-Paul | N. Hahn | S. Hurvitz | A. Noonan | R. Shroff | S. Olwill | M. Matrana | A. Krishnamurthy | M. Zettl | P. Jolicoeur | K. Aviano | L. Mar.